EXAGEN INC. 8-K

What Happened

• Exagen Inc. announced that director Ana Hooker resigned from the Board of Directors and all board committees effective April 17, 2026. Ms. Hooker had been a member of the Audit Committee and served as chair of the Nominating and Corporate Governance Committee. The company stated her resignation was not due to any disagreement with the company’s operations, policies or practices.

Key Details

• Resignation effective date: April 17, 2026.
• Board size reduced from 8 members to 7 members as of the effective time.
• Ms. Hooker’s prior roles: Audit Committee member and Chair of the Nominating & Corporate Governance Committee.
• The filing lists the updated committee memberships following her departure.

Why It Matters

• A change in board composition can affect corporate oversight and governance, particularly because Ms. Hooker chaired the nominating/governance committee and sat on the audit committee, both important for director selection and financial oversight.
• The company confirmed the departure was not due to any disagreement with management, which signals this was a voluntary governance change rather than a public dispute. Investors should note the updated board makeup and any future announcements about committee reassignments or a potential replacement director.